Silence Therapeutics (SLN) Leases (2023 - 2025)
Silence Therapeutics' Leases history spans 3 years, with the latest figure at $167000.0 for Q4 2025.
- For Q4 2025, Leases rose 6.37% year-over-year to $167000.0; the TTM value through Dec 2025 reached $167000.0, up 6.37%, while the annual FY2025 figure was $167000.0, 6.37% up from the prior year.
- Leases for Q4 2025 was $167000.0 at Silence Therapeutics, down from $192000.0 in the prior quarter.
- Across five years, Leases topped out at $370000.0 in Q4 2023 and bottomed at $58000.0 in Q2 2025.
- The 3-year median for Leases is $162000.0 (2024), against an average of $175166.7.
- The largest annual shift saw Leases plummeted 57.57% in 2024 before it rose 6.37% in 2025.
- A 3-year view of Leases shows it stood at $370000.0 in 2023, then tumbled by 57.57% to $157000.0 in 2024, then grew by 6.37% to $167000.0 in 2025.
- Per Business Quant, the three most recent readings for SLN's Leases are $167000.0 (Q4 2025), $192000.0 (Q3 2025), and $58000.0 (Q2 2025).